Federal contract award
75N93020P01171
BRILLIANT VIOLET ANTI-HUMAN ANTIBODIES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $8.4K |
| Current contract value | $8.4K |
| Potential contract value / ceiling | $8.4K |
| Start date | Aug 22, 2020 |
| Current end date | Nov 29, 2022 |
| Potential end date | Nov 29, 2022 |
| Latest award activity | Mar 28, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 28, 2025 | P00002 | $-2.9K | BRILLIANT VIOLET ANTI-HUMAN ANTIBODIES |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.